drugset
drugset / Trial / NCT04702789

Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.

NCT04702789 ↗

Phase 4 Terminated 28 enrolled Laboratorios Sophia S.A de C.V.
RandomizedParallel-groupDouble-blindTreatment

Summary

Phase IV randomized, double blind, multicenter, parallel group clinical study to evaluate the efficacy of the combined use of Krytantek Ofteno PF® and Gaap Ofteno PF®, both applied every 12 hours, versus the use of Eliptic Ofteno PF® Plus Gaap Ofteno PF®, both applied every 12 hours, in patients with open angle glaucoma or ocular hypertension during 90 days

Timeline

Start
2021-10-19
Primary completion
2023-11-23
Completion
2023-11-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule 0.2 % Other
Subject Dorzolamide Small molecule 2 % Other
Subject Latanoprost Small molecule 0.005 % Other
Subject Timolol Other / unclassified 0.5 % Other

Indications

ocular hypertension open-angle glaucoma